Computational Biology in Anti-Tuberculosis Drug Discovery

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 319-326

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Approaches to Target Discovery: - Evaluating Targets for Antituberculosis Drug Discovery Programmes

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 120-126

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic drug discovery: lessons from the past and thoughts for the future

By Wu Jessie M   Staton Carolyn A  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 8, 2012-08 ,pp. : 723-743

Informa Healthcare

Access to resources Recommend Favorite

Magnetic resonance imaging in drug discovery: lessons from disease areas

By Beckmann N.   Laurent D.   Tigani B.   Panizzutti R.   Rudin M.  

Drug Discovery Today, Vol. 9, Iss. 1, 2004-01 ,pp. : 35-42

Elsevier

Access to resources Recommend Favorite

Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas

By Maruo Takeshi   Ohara Noriyuki   Yoshida Shigeki   Nakabayashi Koji   Sasaki Hiroko   Xu Qin   Matsuo Hiroya   Sitruk-Ware Regine   Yamada Hideto  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 9, 2011-09 ,pp. : 897-911

Informa Healthcare

Access to resources Recommend Favorite